相关实验视频

Updated: Sep 19, 2025

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia

Published on: September 12, 2020

试验性帕金森症是由注射到基底腺体的疹毒素引起的

Patrik Meglić¹, Petra Šoštarić¹, Davor Virag¹

¹Laboratory of Molecular Neuropharmacology, Department of Pharmacology and Croatian Institute of Brain Research, University of Zagreb School of Medicine, Zagreb, Croatia.

British journal of pharmacology

|June 4, 2025

概括

刺痛神经毒素 (TeNT) 注射到基底腺中会导致暂时的运动问题,类似于帕金森症. 这些效应因注射部位而异,突出了TeNT的作用.

科学领域:

神经科学是一个神经科学.
运动控制研究运动控制研究
药理学药理学是指药理学的学科.

背景情况:

基底腺中的局部和远程抑制电路对于自愿运动至关重要.
这些电路的功能障碍有助于导致超金字塔运动障碍.
风风神经毒素 (TeNT) 选择性地抑制了GABA-活性突触传输.

研究的目的:

为了研究TeNT在注射到特定的基底腺核时的运动效应.
了解GABA-活性传递在基底腺节运动控制中的作用.
探索TeNT作为研究运动障碍的工具.

主要方法:

鼠被单方面注射TeNT到内球体 (GPi),黑色体 (SN) 或尾巴门 (CPu).
通过协调,步态和旋转行为测试来评估运动功能.
在注射后测量了神经元标记者的区域蛋白质水平.

主要成果:

对GPi和CPU的TeNT注射导致显著的运动障碍,包括脚步长度减少和步伐减慢.
在梁行走过程中,CPU注射导致逆侧足部错位.
观察到自发循环 (旋转行为),运动缺陷在两周内逐渐恢复,没有相关的发症或改变神经元标记水平.

结论:

基底腺体TeNT注射会诱导暂时的低动力运动功能障碍,模仿实验性帕金森症.
运动症状的呈现取决于所针对的基底腺区域而异.
TeNT 作为一种有价值的非神经退行性药物,用于研究 GABA-活性基底质回路异常的运动控制.

关键词:

基底性腺 (Basal Ganglia) 是一个增加了赤字增加了赤字低动力运动障碍运动障碍旋转行为旋转行为风毒素是一种毒素.

更多相关视频

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test

Published on: January 15, 2010

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test

Published on: May 31, 2016

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.